Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cantizolamide vs linezolid for central nervous system tuberculosis
ChiCTR2400088345Phase 4Not yet recruiting
- Sponsor
- Changchun Infectious Disease Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of contezolid in cerebral tuberculosis (CNS-TB) (2 arms), sponsored by Changchun Infectious Disease Hospital. Primary endpoints: Physical signs and physical examination, Imaging examination and 4 more. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
contezolid
03
Conditions
cerebral tuberculosis (CNS-TB)
Beyond the preview
Go deeper on ChiCTR2400088345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088345.